Clinical evaluation of heart failure patients: what good are biomarkers bringing us?

por de Boer, R. A.
Publicado 2014

Correction to: Amino acid loss during CVVH in critically ill patients

por Stapel, S. N., de Boer, R., Oudemans, H. M.
Publicado 2018

Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide

por Siderov, J, Prasad, P, De Boer, R, Desai, J
Publicado 2002

Recombinant Human Epo Treatment: Beneficial in Chronic Kidney Disease, Chronic Heart Failure, or Both?: Editorial to: “Correction of Anemia with Erythropoietin in Chronic Kidney Di...

por Belonje, A. M. S., de Boer, R. A., Voors, A. A.
Publicado 2008

The fibrosis-cell death axis in heart failure

por Piek, A., de Boer, R. A., Silljé, H. H. W.
Publicado 2016

A multi-centre randomized, open-label phase II trial of continuous erlotinib plus gemcitabine or gemcitabine as first-line therapy in ECOG PS2 patients with advanced non-small cell...

por MICHAEL, M., PAVLAKIS, N., CLINGAN, P., DE BOER, R., JOHNSTON, M., CLARKE, S.
Publicado 2012

Biomarkers in heart failure with preserved ejection fraction

por Meijers, W. C., van der Velde, A. R., de Boer, R. A.
Publicado 2016

Progress in heart failure management in the Netherlands and beyond: long-term commitment to deliver high-quality research and patient care

por Meems, L. M. G., van Veldhuisen, D. J., de Boer, R. A.
Publicado 2020

Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides

por Meijers, W. C., Hoekstra, T., Jaarsma, T., van Veldhuisen, D. J., de Boer, R. A.
Publicado 2016

Awareness of atrial fibrogenesis and natriuretic peptide release

por Meijers, W. C. F. W., Jaarsma, T., van Veldhuisen, D. J., Hoekstra, T., de Boer, R. A.
Publicado 2017

Cardiac foetal reprogramming: a tool to exploit novel treatment targets for the failing heart

por van der Pol, A., Hoes, M. F., de Boer, R. A., van der Meer, P.
Publicado 2020

Heart transplantation in the Netherlands: A national achievement

por Damman, K., Brügemann, J., De Boer, R. A., Erasmus, M. E., van den Broek, S. A. J.
Publicado 2018

Telemedicine in heart failure—more than nice to have?

por Eurlings, C. G. M. J., Boyne, J. J., de Boer, R. A., Brunner-La Rocca, H. P.
Publicado 2018

P74. A Good Manufacturing Practice procedure to generate therapeutic numbers of highly pure anti-leukaemic virus-specific T-cells

por van Loenen, MM, de Boer, R, van Liempt, E, Hagedoorn, RS, Meij, P, Jedema, I, Falkenburg, JHF, Heemskerk, MHM
Publicado 2014

The HPD - CDC 3200 system at Amsterdam

por de Boer, R J, Harting, D, Hertzberger, L O, Holthuizen, D J, Snoek, C, Van Dam, P H A, Van Leeuwen, W M
Publicado 1970

Immune checkpoint inhibitor–associated myocarditis: Case reports and a review of the literature

por Osinga, T. E., Oosting, S. F., van der Meer, P., de Boer, R. A., Kuenen, B. C., Rutgers, A., Bergmann, L., Oude Munnink, T. H., Jalving, M., van Kruchten, M.
Publicado 2022

Prevalence and cardiac phenotype of patients with a phospholamban mutation

por Hof, I. E., van der Heijden, J. F., Kranias, E. G., Sanoudou, D., de Boer, R. A., van Tintelen, J. P., van der Zwaag, P. A., Doevendans, P. A.
Publicado 2018

EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer

por Van den Brande, J, Schöffski, P, Schellens, J H M, Roth, A D, Duffaud, F, Weigang-Köhler, K, Reinke, F, Wanders, J, de Boer, R F, Vermorken, J B, Fumoleau, P
Publicado 2003

The phospholamban (PLN) p.Arg14del risk model; Longitudinal validation and reevaluation of predictors regarding sudden cardiac death (SCD)

por Van Der Heide, M Y C, Verstraelen, T E, Van Lint, F H M, Bosman, L P, De Brouwer, R, Proost, V M, Germans, T, Dickhoff, C, Schoonderwoerd, B A, Houweling, A C, Gimeno-Blanes, J R, De Boer, R A, Cox, M G P J, Van Tintelen, P, Wilde, A A M
Publicado 2023

Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)

por Coleman, R.E., Collinson, M., Gregory, W., Marshall, H., Bell, R., Dodwell, D., Keane, M., Gil, M., Barrett-Lee, P., Ritchie, D., Bowman, A., Liversedge, V., De Boer, R.H., Passos-Coelho, J.L., O'Reilly, S., Bertelli, G., Joffe, J., Brown, J.E., Wilson, C., Tercero, J.C., Jean-Mairet, J., Gomis, R., Cameron, D.
Publicado 2018